Christer Borgfeldt
41 – 50 of 86
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Increased HPV detection by the use of a pre-heating step on vaginal self-samples analysed by Aptima HPV assay
- Contribution to journal › Article
-
Mark
Primary treatment patterns and survival of cervical cancer in Sweden : A population-based Swedish Gynecologic Cancer Group Study
- Contribution to journal › Article
-
Mark
Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study
- Contribution to journal › Article
- 2018
-
Mark
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study
- Contribution to journal › Article
-
Mark
Data quality in the Swedish Quality Register of Gynecologic Cancer – a Swedish Gynecologic Cancer Group (SweGCG) study
- Contribution to journal › Article
-
Mark
Confounders other than comorbidity explain survival differences in Danish and Swedish ovarian cancer patients – a comparative cohort study
- Contribution to journal › Article
-
Mark
A Swedish population-based evaluation of benign hysterectomy, comparing minimally invasive and abdominal surgery
- Contribution to journal › Article
-
Mark
Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples
- Contribution to journal › Article
-
Mark
Prevalence of high-risk HPV in postmenopausal women with benign cervical cytology - A population-based cohort study
- Contribution to journal › Article
- 2017
-
Mark
Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)
- Contribution to journal › Article
